KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Idexx Laboratories (IDXX) Receivables - Other (2018 - 2025)

Idexx Laboratories has reported Receivables - Other over the past 8 years, most recently at $312.7 million for Q4 2025.

  • Quarterly results put Receivables - Other at $312.7 million for Q4 2025, up 26.96% from a year ago — trailing twelve months through Dec 2025 was $312.7 million (up 26.96% YoY), and the annual figure for FY2025 was $312.7 million, up 26.96%.
  • Receivables - Other for Q4 2025 was $312.7 million at Idexx Laboratories, up from $288.7 million in the prior quarter.
  • Over the last five years, Receivables - Other for IDXX hit a ceiling of $312.7 million in Q4 2025 and a floor of $122.6 million in Q1 2021.
  • Median Receivables - Other over the past 5 years was $209.0 million (2023), compared with a mean of $211.0 million.
  • Biggest five-year swings in Receivables - Other: skyrocketed 47.05% in 2021 and later increased 9.91% in 2025.
  • Idexx Laboratories' Receivables - Other stood at $159.9 million in 2021, then increased by 19.32% to $190.8 million in 2022, then grew by 16.93% to $223.1 million in 2023, then grew by 10.4% to $246.3 million in 2024, then grew by 26.96% to $312.7 million in 2025.
  • The last three reported values for Receivables - Other were $312.7 million (Q4 2025), $288.7 million (Q3 2025), and $274.8 million (Q2 2025) per Business Quant data.